Current automated insulin delivery platforms — like those offered by Insulet, Tandem Diabetes Care, Medtronic, Beta Bionics and Sequel Med Tech — link separate devices. The pump itself is either tubeless and placed on the body, or worn on clothing with tubing delivering insulin to the body. They communicate with a CGM worn elsewhere on the body — typically the arm or the torso.

In the case of PharmaSens and SiBionics, all-in-one really means all-in-one. Combining pump and CGM into one device, the companies hope to bring a differentiated offering to the diabetes community.

Last week, the two companies announced plans to develop the next-generation Niia Signature insulin patch pump. The all-in-one wearable device would integrate insulin delivery from Switzerland-based PharmaSens and glucose sensing from China-based SiBionics into a single, compact automated patch pump system.